Delivery Order SPE2DB24D9245-SPE2DB25FHMHV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for STELARA 90 mg/mL syringes. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for the supply of Stelara 90 mg/ml syringes. The contract is issued under a firm fixed-price arrangement with an ultimate completion date of October 3, 2025, and represents a non-set-aside award. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for $16,249.95 to supply Stelara 90 mg/mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $16,249.95 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries an ultimate completion date of October 2, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/mL syringes. This firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency on June 30, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries a firm fixed-price structure with an ultimate completion date of July 22, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB24D9245Indefinite Delivery Contract
- SPE2DB24D9245-SPE2DB25FHMHVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The contract, awarded on September 15, 2025, carries a firm fixed-price structure with an ultimate completion date of October 6, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of DMS Pharmaceutical Group's substantial work with the federal government in pharmaceutical distribution to military and federal healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Stelara, an immunosuppressant biologic medication, falls within the extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies through this indefinite delivery vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/15/25 |